Emerging a Novel VOPP1-EGFR Fusion Coexistent With T790M as an Acquired Resistance Mechanism to Prior Icotinib and Sensitive to Osimertinib in a Patient With EGFR L858R Lung Adenocarcinoma: A Case Report

BACKGROUND: Epidermal growth factor receptor (EGFR) fusions are rare genomic events in non-small-cell lung cancer (NSCLC). Clinical support and evidence to guide management are absent for NSCLC patients harboring EGFR fusion. CASE PRESENTATION: In this case report, we describe a 69-year-old female w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xia, Peng, Weiwei, Zeng, Zhimin, Cai, Jing, Liu, Anwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727519/
https://www.ncbi.nlm.nih.gov/pubmed/35004270
http://dx.doi.org/10.3389/fonc.2021.720819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727519/
https://www.ncbi.nlm.nih.gov/pubmed/35004270
http://dx.doi.org/10.3389/fonc.2021.720819

Ejemplares similares